SANUWAVE Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reported that scientific findings titled “Extracorporeal Shock Wave Stimulation of Osteoprogenitor Cells” were presented at the 2009 International Bone-Tissue-Engineering Congress (“Bone-Tec”) in Hannover, Germany, which was held October 9-11, 2009.
Dr. Myron Spector, PhD, Professor of Orthopaedic Surgery (Biomaterials) at Harvard Medical School, Director of Orthopaedic Research at Brigham and Women’s Hospital and Director of Tissue Engineering at VA Boston Healthcare System, was an invited guest speaker at the Conference. The
Stem cells exposed to microgravity express different proteins than those grown in normal gravity, say Australian researchers (…)
Dr Burns, along with graduate researchers Elizabeth Blaber and Helder Marcal, used a NASA rotating-wall vessel to simulate microgravity, which is experienced by astronauts in low Earth orbit, to analyse its effect on human embryonic stem cells.
Stem cells are cells that have yet to differentiate into cells with specialised functions (…)
Associate Professor Ernst Wolvetang of the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland says while it’s difficult to judge the research prior to publication, it is a “novel
The study Sun has been working on in Dr. Farshid Guilak’s laboratory has found that engineered cartilage constructed from a particular type of stem cell integrate well with host cartilage, but not necessarily in a uniform way.
Sun was one of about thirty biomedical engineering students who presented at the department’s graduation with distinction reception on April 26. Other students have been working on exciting projects in optic imaging of tumors, synthetic biology, and deep brain stimulation, among other topics.
Sun’s project focused on how induced pluripotent stem cells can be used to study cartilage regeneration and repair.
International Stem Cell Corporation announced that scientists in its wholly-owned subsidiary, Lifeline Cell Technology (LCT), have developed a technology to modify human stem cells by using engineered proteins, called “transducible transcription factors” or “TTFs.” TTFs are designed to pass into stem cells and direct the stem cells to change into specific cell types that can be both therapeutically-useful and can be used as revenue-generating research products.
In contrast to more traditional cell therapy methods this technology does not require the use of viruses or chemicals, and has the potential to produce safe therapeutic cells from stem cells. In addition, the
Image via Wikipedia
The University of Minnesota is proceeding with embryonic stem cell research, despite an anti-abortion group’s claim that it is illegal under a new ban on the use of state tax dollars for human cloning.
Minnesota Citizens Concerned for Life called on the university Tuesday to “cease its pursuit of human cloning and to end its violation of state law through its ongoing destruction of human embryos.” The organization cited the new cloning ban, along with legislative testimony from a U executive that the ban would stifle “ongoing” research if passed.
University spokeswoman Mary Koppel said the executive’s comments referred